These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27501282)

  • 1. Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.
    Souma N; Isakova T; Lipiszko D; Sacco RL; Elkind MS; DeRosa JT; Silverberg SJ; Mendez AJ; Dong C; Wright CB; Wolf M
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3779-3786. PubMed ID: 27501282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.
    Shah NH; Dong C; Elkind MS; Sacco RL; Mendez AJ; Hudson BI; Silverberg S; Wolf M; Rundek T; Wright CB
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2048-53. PubMed ID: 26112008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS).
    Wright CB; Dong C; Stark M; Silverberg S; Rundek T; Elkind MS; Sacco RL; Mendez A; Wolf M
    Neurology; 2014 May; 82(19):1700-6. PubMed ID: 24706015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study.
    Hartmann A; Rundek T; Mast H; Paik MC; Boden-Albala B; Mohr JP; Sacco RL
    Neurology; 2001 Dec; 57(11):2000-5. PubMed ID: 11739816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
    Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race and Ethnic Disparities in Stroke Incidence in the Northern Manhattan Study.
    Gardener H; Sacco RL; Rundek T; Battistella V; Cheung YK; Elkind MSV
    Stroke; 2020 Apr; 51(4):1064-1069. PubMed ID: 32078475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 as a predictor of cardiovascular and all-cause mortality in prospective studies.
    Qin Z; Liu X; Song M; Zhou Q; Yu J; Zhou B; Wu Y; He Y; Huang L
    Atherosclerosis; 2017 Jun; 261():1-11. PubMed ID: 28411494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
    Wright CB; Shah NH; Mendez AJ; DeRosa JT; Yoshita M; Elkind MS; Sacco RL; DeCarli C; Rundek T; Silverberg S; Dong C; Wolf M
    Stroke; 2016 Apr; 47(4):923-8. PubMed ID: 26956260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
    PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan.
    Brickman AM; Schupf N; Manly JJ; Luchsinger JA; Andrews H; Tang MX; Reitz C; Small SA; Mayeux R; DeCarli C; Brown TR
    Arch Neurol; 2008 Aug; 65(8):1053-61. PubMed ID: 18695055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study.
    Pool LR; Kershaw KN; Gordon-Larsen P; Gutiérrez OM; Reis JP; Isakova T; Wolf M; Carnethon MR
    J Ren Nutr; 2020 Nov; 30(6):509-517. PubMed ID: 32147284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
    Panwar B; Jenny NS; Howard VJ; Wadley VG; Muntner P; Kissela BM; Judd SE; Gutiérrez OM
    Stroke; 2015 Feb; 46(2):322-8. PubMed ID: 25563643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study.
    Gardener H; Wright CB; Gu Y; Demmer RT; Boden-Albala B; Elkind MS; Sacco RL; Scarmeas N
    Am J Clin Nutr; 2011 Dec; 94(6):1458-64. PubMed ID: 22071704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study.
    Luna JM; Moon Y; Liu K; Spitalnik S; Paik M; Sacco R; Elkind MS
    Age Ageing; 2013 May; 42(3):385-90. PubMed ID: 23321203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.
    Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD
    JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox.
    Willey JZ; Rodriguez CJ; Moon YP; Paik MC; Di Tullio MR; Homma S; Sacco RL; Elkind MS
    Ann Epidemiol; 2012 May; 22(5):303-9. PubMed ID: 22424967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fibroblast growth factor 23 concentration and the risk of mortality in patients undergoing peritoneal dialysis.
    Zhong Z; Feng S; Fu D; Li B; Li Z; Mao H
    Perit Dial Int; 2024 May; 44(3):194-202. PubMed ID: 38449341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
    Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.